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Frequency of Cataract in Iran: 
A Meta‑Analysis and Systematic 
Review
Hosien Shahdadi1, Mohammad Naim Aminifard2, Abbas Balouchi1,3, 
Hosein Rafiemanesh4,5, Jasem Allahyari1
Abstract:
PURPOSE: Cataract is the leading cause of blindness and the second cause of low vision in the 
world. In the world, Asia has the highest number of blind population. The aim of the present systematic 
review and meta‑analysis was to assess the frequency of clinical cataracts in Iran. 
MATERIALS AND METHODS: The  frequency  of  clinical  cataract was  defined  based  on  the 
international criteria and the measured outcome of the disease. Study selection, data extraction, and 
quality assessment were performed by two independent reviewers. We explored PubMed, Google 
Scholar, ISI Web of Science, and national databases (scientific information database, Magiran) to 
evaluate the clinical cataract of cataract in the Iranian populations from 1995 to July 2017. Statistical 
analysis was performed using STATA 14.0 software. 
RESULTS: Of 283 studies, 27 studies utilized meta‑analysis. In 2017, the pooled overall frequency of 
clinical cataract in 59668 people was 9.27% (95% confidence interval [CI]: 8.09, 10.45, I 2 = 98.82%). 
Based on subgroup analysis, in the random effect method, the frequency of clinical cataract in males 
and females were 8.03% (CI: 6.78, 9.28) and 8.32% (CI: 7.08, 9.55), respectively. 
CONCLUSION: Regarding the high frequency of clinical cataract in Iran, it seems that paying attention 
to the results of the current study and the application of international policy plans may contribute to 
better cataract control in Iran.
Keywords:
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Introduction
According to  the  World Heal th Organization (WHO), cataract is the 
leading cause of blindness and second 
cause of visual impairment in the world.[1] 
More than 80% of cataract patients are 
in low‑income countries.[2] In 80% of 
patients, cataract is curable by surgery, 
but in many countries, a lot of cataract 
patients are blind due to low access to 
suitable cataract surgery service.[3] The 
different types of cataracts are as follows 
age‑related cataract (senile cataract), 
traumatic cataract, congenital cataract, 
and secondary cataract. Age‑related 
cataract is the most common cataract in 
the world.[4‑6] According to meta‑analysis 
and systematic review studies, cataract 
is the cause of the highest percentage 
of blindness (41.7%–42%) in Asia. [5,6] 
Considering the high prevalence of cataract 
in Asian countries like Iran,[4] and the 
importance of determining a correct and 
evidence‑based estimation of cataract 
prevalence in developing countries, this 
study evaluated the frequency of clinical 
cataract in Iran from 1990 to 2017. Another 
reason for conducting this study is due 
to the imposition of a large portion of 
health budget for cataract treatment 
and to help policymakers in eliminating 
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cataract, which is one of the six important eye burden 
diseases according to VISION 2020: The right to sight 
program.[7] Iran has a population of 80 million and is 
located in the eastern Mediterranean region in West 
Asia and consists of 31 provinces.
Materials and Methods
Eligibility criteria
The methods adopted for this systematic review have been 
developed in accordance with the guidelines detailed on 
the Preferred Reporting Items for Systematic Reviews and 
Meta‑Analyses.[8] Observational studies (cross‑sectional, 
case–control, and cohort) were included in present 
study. Case series, case reports, clinical trials, and 
reviews (systematic review and narrative reviews) were 
excluded from the study. The target populations were 
general populations, patients with eye disease and 
children. The frequency of clinical cataract was measured 
in this study. Cataract defined as clouding of the lens of 
the eye which prevents clear vision.[9] Minimum required 
sample size was ≥25 patients.
Search strategy and databases
Literature review was done using the medical subject 
headings and keywords related to cataract frequency 
in Iran. We explored the electronic databases including 
international databases (MEDLINE [PubMed interface], 
Google Scholar and ISI Web of science [web of 
science interface]) and national databases (scientific 
information database [SID] and Magiran), National 
key journal (Journal of Current Ophthalmology) for 
relevant studies. No settings and language limits were 
imposed on the search. The specific search strategies 
were created by a health sciences librarian with expertise 
in systematic review searching. PRESS standard used 
for creating the search strategy.[10] The MEDLINE search 
strategy was adopted to search in another databases. 
Moreover, PROSPERO searched for the ongoing or 
recently completed systematic reviews. Keywords 
that used in search strategy were cataract, prevalence, 
frequency, incidence, population and Iran that were 
combined with Boolean operators included AND, OR, 
and NOT.
Study selection
The Endnote software was used to upload the literature 
review results. The team developed the test screening 
questions and forms for Level 1 and 2 assessments based 
on the inclusion and exclusion criteria. Citation abstracts 
and full‑text articles were uploaded by screening questions 
to the Endnote. Before the formal screening process, a 
calibration exercise was undertaken to pilot and refine 
the screening questions. The formal screening process of 
titles and abstracts were conducted by two researchers 
according to the eligibility criteria, and the consensus 
method was used for solving controversies among the two 
researchers. The full text was obtained for all titles that meet 
the inclusion criteria. Additional information was obtained 
from the study, to resolve queries regarding the eligibility 
criteria. We recorded the reasons for the exclusion criteria. 
Neither of the review authors was blinded to the journal 
titles or to the study authors or institutions.
Data extraction and quality assessment
Extrac ted  data  i tems  inc luded the  genera l 
information (authors, title, source, and year of 
publication), study characteristics (study design), 
participant characteristics (demographics, sample size), 
and outcome measures (frequency of cataract). The 
tool of Hoy et al. was used for assessing the quality of 
studies.[11] This decision was made independently by 
two review authors based on the criteria for judging the 
risk of bias, in case of any disagreement, the consensus 
method was used to resolve any controversies.
Data synthesis
All the eligible studies were included in the synthesis 
after a systematic review. Data were combined with the 
forest plot. The overall frequency of clinical cataract was 
estimated by the random‑effects model. The heterogeneity 
of the preliminary studies was evaluated with I2 tests. 
Subgroup analysis was conducted to diagnose the 
heterogeneity based on the kind of study participants, sex, 
and age. Meta‑analysis was performed using the STAT 14 
Statistics software (StataCorp, Texas, USA).
Results
Study selection
A total of 283 articles were retrieved from the initial 
search in different databases. Out of 261 nonduplicated 
studies in the title and abstracts screening process, 203 
studies were excluded due to unrelated titles. Of 58 
studies, 27 studies met the eligibility criteria. Of the 31 
excluded studies, six studies were review, three studies 
were study protocol, five studies were letter to editor, 
four studies did not have full text, and 13 studies could 
not meet the least quality requirement for inclusion 
in the study. The list of studies is available at http://
uploadboy.me/q5u7148ao4ld/list of final included 
papers.pdf.html [Figure 1].
Study characteristics
These studies were conducted on 59668 patients in 
22 years, the mean age of the participants was 48.8 years 
and most of them were female (n = 33923; 56.8%). 
Of the 27 included studies, 26 studies provided 
only cross‑sectional data, one study provided only 
retrospective descriptive data. Studies were conducted 
only in 12 out of 31 provinces in Iran. Most studies were 
carried out in Tehran province (n = 9). Most studies 
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were conducted in hospitals (n = 12), utilized a cluster 
sampling method (n = 12), had low risk of bias (n = 21), 
and was conducted in a period of 1 year (n = 14) [Table 1].
Meta‑analysis frequency of clinical cataract
Based on the results of the random‑effect method, the 
overall frequency of clinical cataract in 59668 people 
was 9.27% (95% confidence interval [CI]: 8.09, 10.45, 
I2 = 98.82%). Subgroup analysis was conducted for the 
diagnosis of heterogeneity based on the kind of study 
participants, sex, and age.
The frequency of clinical cataract was about three times 
more in people with vision problems compared to 
those without; such that the pool estimated (in random 
model) frequency of clinical cataract in people without 
and with vision problems were 7.00% (95% CI: 5.72, 8.27, 
I2 = 98.92%) and 16.44% (95% CI: 11.15, 21.73, I2 = 98.16%), 
respectively [Figure 2].
Based on subgroup analysis using the random‑effect 
method, the frequency of clinical cataract in males and 
females were 8.03% (95% CI: 6.78, 9.28, I2 = 97.55%) and 
8.32% (95% CI: 7.08, 9.55, I2 = 97.77%), respectively, 
and a difference was also found in the study participants 
subgroup [Table 2].
Based on subgroup analysis using the random‑effect 
method, the frequency of clinical cataract in the study 
with participants of mean age >50 years and <50 years 
were 16.82% (95% CI: 12.71, 20.94, I2 = 99.5540 and 
4.92% (95% CI: 3.98, 5.86, I2 = 98.82%).
Discussion
Cataract is the major cause of blindness in the world, 
and its prevalence rate increased in the last decade. The 
present systematic review study includes cross‑sectional 
and retrospective descriptive studies on the frequency 
of clinical cataract over the past 22 years which were 
Figure 1: Flow diagram of article selection process
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Table 1: Summary of Studies characteristic
ID Author (year) Province Sampling 
method
Design Setting Sample 
size
Age Study 
duration
Risk of 
bias
Target 
population
1 Abdollahi et al. (2001)[12] Tehran Census Cross‑sectional Hospital 150 16.3 4 months Moderate All ages
2 Aghadoost et al. (2006)[13] Esfahan Census Cross‑sectional Hospital 420 58/5 1 year Low All ages
3 Akhgary et al. (2014)[14] Tehran Census Cross‑sectional Hospital 204 45.2 1 year Moderate All ages
4 Besharati et al. (2006)[15] Yazd Census Cross‑sectional Welfare 
center
109 24.6 9 months Low All ages
5 Faeze et al. (2016)[16] Gilan Purposive 
sampling
Retrospective Hospital 180 67.7 1 year Low All ages
6 Feghhi et al. (2009)[17] Khuzestan Cluster 
sampling
Cross‑sectional Health 
center
6970 24.7 1 year Low All ages
7 Fotouhi et al. (2004)[18] Tehran Cluster 
sampling
Cross‑sectional Private eye 
clinic
4565 30.1 1 year Low All ages
8 Hashemi et al. (2012)[19] Semnan Cluster 
sampling
Cross‑sectional Primary 
care center
5190 50.9 1 year Moderate ≥40
9 Hashemi et al. (2017)[20] Mazandaran Cluster 
sampling
Cross‑sectional Health 
center
937 64.7 1 year Low ≥54
10 Hashemi et al. (2015)[21] Khorasan 
Razavi
Cluster 
sampling
Cross‑sectional Hospital 2452 31.1 2 months Low All ages
11 Hashemi et al. (2017)[22] Mazandaran, 
Khuzestan
Cluster 
sampling
Cross‑sectional Health 
center
3095 37.6 5 months Low All ages
12 Hatef et al. (2008)[23] Tehran Cluster 
sampling
Cross‑sectional Private eye 
clinic
4354 29.19 1 year Low All ages
13 Javadi et al. (2004)[24] Tehran Census Cross–sectional Health 
center
2160 55.1 1 year Low ≥40
14 Katibeh et al. (2015)[25] Yazd Cluster 
sampling
Cross‑sectional Health 
center
2023 59.8 1 year Low ≥40
15 Katibeh et al. (2014)[26] Tehran Cluster 
sampling
Cross‑sectional Health 
center
2819 58 1 year Moderate ≥50
16 Khalaj et al. (2013)[27] Qazvin Simple random 
sampling
Cross‑sectional Hospital 446 62.9 1 year Low ≥50
17 Maeiiat et al. (2013)[28] Ardabil Census Cross–sectional Welfare 
center
403 33.2 7 months Low All ages
18 Mirdehghan et al. (2005)[29] Tehran Convenience 
sampling
Cross‑sectional Hospital 362 13.5 1 year Low Children
19 Nodehi Moghadam 
et al. (2015)[30]
Tehran Purposive 
sampling
Cross‑sectional Private eye 
clinic
392 71.6 2 years Low ≥60
20 Nowroozpoor Dailami 
et al. (2011)[31]
Mazandaran Census Cross–sectional Hospital 262 29 2 years Moderate All ages
21 Ostadi‑Moghaddam 
et al. (2007)[32]
Khorasan 
Razavi
Purposive 
sampling
Cross‑sectional School 286 14.2 4 months Moderate Children
22 Shahriari et al. (2007)[33] Sistan V 
Balouchistan
Cluster 
sampling
Cross‑sectional Hospital 5446 31.1 1.5 years Low All ages
23 Sharifi (2009)[34] Azerbaijan 
Sharghi
Simple random 
sampling
Cross‑sectional Private eye 
clinic
500 40.5 6 months Low All ages
24 Shirzadeh et al. (2007)[35] Khorasan 
Razavi
Cluster 
sampling
Cross‑sectional Health 
center
2508 28.28 2 years Low All ages
25 Soori et al. (2011)[36] Tehran Cluster 
sampling
Cross‑sectional Hospital 11,975 27.7 1 year Low All ages
26 Yaqubi and Hosseini 
(2004)[37]
Khorasan 
Jonobi
Census Cross‑sectional Hospital 523 67.2 7 years Low ≥50
27 Yekta et al. (2013)[38] Mazandaran Random cluster 
sampling
Cross‑sectional Hospital 937 64.7 6 months Low ≥55
performed on 59,668 people. According to the main 
results of this study, the frequency of clinical cataract 
in Iran is 9.27%. The results of a study by ACOSTA 
showed that the prevalence of cataract in Europe, USA, 
and Australia is very considerable from 5% to 30%.[39] 
The prevalence/frequency of cataract in Iran is equal to 
some other Asian countries, such as Taiwan (10.7%)[40] 
and Singapore (9.7%),[41] and higher than countries such 
as Indonesia (2.2%)[42] and Nepal (5.3%).[43] This may be 
due to differences in the type of studies, sample sizes, 
and accessibility to effective eye‑care services. Despite 
scientific advances in cataract control from 1990 to 2010, 
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the increase in global incidence rate of cataract is 1% 
among men and 3% among women. It is still the most 
important cause of blindness and second leading cause 
of visual impairment in the world.[6] Cataract accounts 
for >33.4% of blindness worldwide and >42% of it in Asian 
countries including Iran.[44] The current study reported 
Figure 2: The frequency of clinical cataract among primary studies and frequency of clinical cataract of pooled estimate in Iran. CI: Confidence interval; ES: Effect size
Table 2: Subgroup analysis done for diagnosis of heterogeneity base on kind of study participants and sex
ID First author Male Female
ES 95% CI for ES Percentage weight ES 95% CI for ES Percentage weight
People with vision problems
1 Abdollahi 24.77 17.00‑33.96 1.59 26.83 14.22‑42.94 0.71
2 Aghadoost 40.32 33.21‑47.75 1.90 39.32 33.02‑45.89 2.22
4 Besharati 9.59 3.94‑18.76 2.00 13.89 4.67‑29.50 0.97
5 Faeze 33.33 23.24‑44.68 1.13 45.45 35.41‑55.77 1.21
17 Maeiiat 8.61 5.41‑12.86 3.49 9.43 5.38‑15.08 3.04
19 Mirdehghan 13.33 9.05‑18.69 2.92 13.82 8.76‑20.34 2.56
21 Nowroozpoor Dailami 3.06 1.13‑6.54 4.09 4.55 0.95‑12.71 2.78
24 Sharifi 15.60 11.57‑2.37 3.11 27.52 21.71‑33.96 2.36
26 Soori 3.74 3.21‑4.33 4.79 3.66 3.24‑4.11 5.12
27 Yaqubi 3.86 1.94‑6.80 4.18 3.78 1.74‑7.06 4.30
Sub‑total random pooled ES 14.26 9.70‑18.82 29.22 18.00 11.37‑24.63 25.28
People without vision problems
3 Akhgary 2.21 0.46‑6.31 4.06 1.47 0.04‑7.92 4.04
6 Feghhi 3.30 2.68‑4.03 4.77 2.69 2.22‑3.23 5.11
7 Fotouhi 1.10 0.68‑1.68 4.80 1.51 1.08‑2.05 5.12
8 Hashemi 0.41 0.19‑0.77 4.82 0.5 0.28‑0.83 5.15
9 Hashemi 30.57 26.28‑35.14 3.06 29.48 25.52‑33.68 3.35
10 Hashemi 1.62 0.98‑2.52 4.75 1.87 1.2‑2.77 5.06
11 Hashemi 2.23 1.51‑3.16 4.74 2.18 1.54‑2.97 5.08
12 Hatef 1.21 0.76‑1.83 4.79 1.38 0.96‑1.91 5.12
13 Javadi 12.16 10.00‑14.61 4.18 11.89 10.21‑13.74 4.68
14 Katibeh 2.13 1.30‑3.27 4.71 1.94 1.2‑2.95 5.04
15 Katibeh 12.15 10.52‑13.93 4.44 12.04 10.35‑13.89 4.68
16 Khalaj 13.52 9.50‑18.47 3.08 10.4 6.55‑15.45 3.23
20 Nodehi Moghadam 42.08 35.19‑49.21 1.99 36.32 29.48‑43.59 2.00
22 Ostadi‑Moghaddam 10.83 6.44‑16.77 2.79 13.18 7.87‑20.26 2.40
23 Shahriari 1.75 1.26‑2.37 4.79 2.1 1.62‑2.66 5.11
25 Shirzadeh 5.03 3.77‑6.56 4.57 6.69 5.48‑8.08 4.89
28 Yekta 3.22 1.77‑5.34 4.45 4.38 2.77‑6.56 4.65
Sub‑total random pooled ES 6.32 4.98‑7.67 70.78 6.17 4.89‑7.45 74.71
Overall random pooled ES 8.03 6.78‑9.28 100 8.32 7.08‑9.55 100
CI: Confidence interval, ES: Effect size
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that its frequency was three times higher in people with 
eye problem than the healthy individuals. Moreover, the 
current study showed that the prevalence/frequency 
of cataract was 16.82% and 4.92% in people older and 
younger than 50 years, respectively.[45,46] Consistent with 
the results of other studies, this finding emphasizes the 
role of gender in this disease in different studies.[6,47] 
Although cataract is categorized as preventable eye 
disease, there are different barriers against the reduction 
of the incidence rate of blindness and visual impairment 
caused by cataract. Some of these barriers are as 
follows: (i) high cost of cataract treatment due to limited 
insurance coverage, (ii) limited knowledge of people 
with cataract specifically in developing countries (which 
present >80% of blindness), such as Iran, resulting in 
a lengthy delay in visiting a doctor, (iii) the lack of 
necessary basic structures, and (iv) unfair distribution 
of medical equipment and ophthalmologists across 
different countries.
Conclusion
Despite the many attempts and marked progress in 
cataract control, this problem has continued to remain 
an issue in Iran and other countries. Regarding the 
high frequency of cataract in Iran, as the major cause 
of blindness worldwide, it seems that paying attention 
to the results of the current study and application of 
international policy plans, such as the WHOs VISION 
2020, may contribute to better cataract control in Iran. It 
is also recommended to conduct a comprehensive study 
at the national level to measure a more accurate cataract 
prevalence rate across the country.
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